Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (461-470 of 561) with videos related to

Pageof 57
Sort By:
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical CystectomyPietro Scilipoti, Marco Moschini, Paolo Zaurito, et al.
World Journal of Urology|November 6, 2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 UpdateAlexandra Masson-Lecomte, Alison Birtle, Benjamin Pradere, et al.
European Urology Oncology|January 8, 2025
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology GuidelinesBhavan Prasad Rai, Kalpesh Parmar, Benjamin Pradere, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
European Urology Oncology|June 20, 2024
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPietro Scilipoti, Aleksander Ślusarczyk, Mario de Angelis, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancerRenate Pichler, Josef Fritz, Sarah Maier, et al.
European Urology|February 22, 2026
Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Roger Li, Patrick J Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 TrialAndrea Necchi, Joep J de Jong, Brigida A Maiorano, et al.
Pageof 57

Showing results (461-470 of 561) with videos related to

Sort By:
Pageof 57
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical CystectomyPietro Scilipoti, Marco Moschini, Paolo Zaurito, et al.
World Journal of Urology|November 6, 2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 UpdateAlexandra Masson-Lecomte, Alison Birtle, Benjamin Pradere, et al.
European Urology Oncology|January 8, 2025
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology GuidelinesBhavan Prasad Rai, Kalpesh Parmar, Benjamin Pradere, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
European Urology Oncology|June 20, 2024
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPietro Scilipoti, Aleksander Ślusarczyk, Mario de Angelis, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancerRenate Pichler, Josef Fritz, Sarah Maier, et al.
European Urology|February 22, 2026
Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Roger Li, Patrick J Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 TrialAndrea Necchi, Joep J de Jong, Brigida A Maiorano, et al.
Pageof 57